EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives

Yang Yu iD, Yunjie Shan, Yinjie Chen, Lingling Ding, Hui Qian iD

Journal of Agricultural and Food Chemistry · 2026

DOI: 10.1021/acs.jafc.6c05063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Agricultural and Food Chemistry, 2026. Verfasst von Yang Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Laboratory Medicine of Jiangsu Province, Department of Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metabolic Diseases, Plant Extracts, Plants. Die Arbeit nennt 202 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions, Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is increasingly viewed as a systemic metabolic disorder rather than as an isolated glycemic defect. It is closely linked to obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), sharing mechanisms such as insulin resistance, chronic inflammation, and interorgan crosstalk among the gut, liver, adipose tissue, pancreas, and central nervous system. Plant-derived nanovesicles (PDNVs) are emerging cross-kingdom nanoplatforms with the potential to modulate metabolic and inflammatory signaling. Evidence from T2DM, obesity, and MASLD models suggests that PDNVs can improve metabolic homeostasis by reprogramming metabolism and reducing inflammation. PDNVs may modulate organ axes, particularly gut–liver and gut–brain axes, and potentially adipose–liver and liver–pancreas axes, partly via context- and tissue-dependent regulation of AMPK-, PI3K-AKT-, and SIRT1-related pathways. Strategies such as structural engineering, surface functionalization, and cargo loading optimization may further enhance the stability, bioavailability, and targeting capacity of PDNVs, thereby supporting their application in metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Metabolic DiseasesPlant ExtractsPlantsHumansAnimals

Stichwörter der Autor:innen

chronic low-grade inflammationinterorgan crosstalkmetabolic disordersplant-derived nanovesiclestype 2 diabetes mellitus

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • Key Laboratory of Laboratory Medicine of Jiangsu Province, Department of Laboratory Medicine, School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu212013, China.
  • Clinical Medical Laboratory Center, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu225300, China.
  • Shanghai TCM-Integrated Hospital, Shanghai University of TCM, Shanghai200082, China.
  • Department of Nephrology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu215300, China.

ORCID-Profile: Yang Yu, Hui Qian

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application

Zitieren

APA

Yu, Y., Shan, Y., Chen, Y., Ding, L., & Qian, H. (2026). Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c05063

Vancouver

Yu Y, Shan Y, Chen Y, Ding L, Qian H. Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c05063

BibTeX
@article{Yu2026,
  author = {Yu, Yang and Shan, Yunjie and Chen, Yinjie and Ding, Lingling and Qian, Hui},
  title = {Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2026},
  doi = {10.1021/acs.jafc.6c05063}
}
Kostenlos starten →